Home ›
Drugs ›
Febuxostat ›
FDA recalls
Febuxostat
FDA recalls
3 rows
Summary of public sources, not medical advice. This page is an automated summary of public information from the FDA, the National Library of Medicine (DailyMed) and CMS Medicare data. It has not been reviewed by a doctor or pharmacist, may be incomplete, out of date or wrong, and does not list every use, dose, warning, interaction or side effect. Do not start, stop or change any medicine, or take a pill you cannot identify, based on this page: ask your doctor or pharmacist and read the official label. In an emergency call 911; for possible poisoning call Poison Control at 1-800-222-1222. Use of this page is subject to our Medical and Data Disclaimer and Terms of Use .
Date Company and reason Class
Mar 3, 2024 Sun Pharmaceutical Industries Inc Class II · Ongoing Jan 24, 2024 Amerisource Health Services LLC Class II · Terminated Jan 17, 2024 Sun Pharmaceutical Industries Inc Class II · Completed
← Back to Febuxostat
Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).